Global Axial Spondyloarthritis Drugs Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Axial Spondyloarthritis Drugs

• 1.1 Definition of Axial Spondyloarthritis Drugs
• 1.2 Axial Spondyloarthritis Drugs Segment by Type
  • 1.2.1 Global Axial Spondyloarthritis Drugs Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Certolizumab Pegol
  • 1.2.3 Etanercept Biosimilar
  • 1.2.4 Ixekizumab
  • 1.2.5 Secukinumab
  • 1.2.6 Others
• 1.3 Axial Spondyloarthritis Drugs Segment by Applications
  • 1.3.1 Global Axial Spondyloarthritis Drugs Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
  • 1.3.4 Home Care
• 1.4 Global Axial Spondyloarthritis Drugs Overall Market
  • 1.4.1 Global Axial Spondyloarthritis Drugs Revenue (2014-2025)
  • 1.4.2 Global Axial Spondyloarthritis Drugs Production (2014-2025)
  • 1.4.3 North America Axial Spondyloarthritis Drugs Status and Prospect (2014-2025)
  • 1.4.4 Europe Axial Spondyloarthritis Drugs Status and Prospect (2014-2025)
  • 1.4.5 China Axial Spondyloarthritis Drugs Status and Prospect (2014-2025)
  • 1.4.6 Japan Axial Spondyloarthritis Drugs Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Axial Spondyloarthritis Drugs Status and Prospect (2014-2025)
  • 1.4.8 India Axial Spondyloarthritis Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Axial Spondyloarthritis Drugs
• 2.3 Manufacturing Process Analysis of Axial Spondyloarthritis Drugs
• 2.4 Industry Chain Structure of Axial Spondyloarthritis Drugs

3 Development and Manufacturing Plants Analysis of Axial Spondyloarthritis Drugs

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Axial Spondyloarthritis Drugs Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Axial Spondyloarthritis Drugs
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Axial Spondyloarthritis Drugs Production and Capacity Analysis
• 4.2 Axial Spondyloarthritis Drugs Revenue Analysis
• 4.3 Axial Spondyloarthritis Drugs Price Analysis
• 4.4 Market Concentration Degree

5 Axial Spondyloarthritis Drugs Regional Market Analysis

• 5.1 Axial Spondyloarthritis Drugs Production by Regions
  • 5.1.1 Global Axial Spondyloarthritis Drugs Production by Regions
  • 5.1.2 Global Axial Spondyloarthritis Drugs Revenue by Regions
• 5.2 Axial Spondyloarthritis Drugs Consumption by Regions
• 5.3 North America Axial Spondyloarthritis Drugs Market Analysis
  • 5.3.1 North America Axial Spondyloarthritis Drugs Production
  • 5.3.2 North America Axial Spondyloarthritis Drugs Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Axial Spondyloarthritis Drugs Import and Export
• 5.4 Europe Axial Spondyloarthritis Drugs Market Analysis
  • 5.4.1 Europe Axial Spondyloarthritis Drugs Production
  • 5.4.2 Europe Axial Spondyloarthritis Drugs Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Axial Spondyloarthritis Drugs Import and Export
• 5.5 China Axial Spondyloarthritis Drugs Market Analysis
  • 5.5.1 China Axial Spondyloarthritis Drugs Production
  • 5.5.2 China Axial Spondyloarthritis Drugs Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Axial Spondyloarthritis Drugs Import and Export
• 5.6 Japan Axial Spondyloarthritis Drugs Market Analysis
  • 5.6.1 Japan Axial Spondyloarthritis Drugs Production
  • 5.6.2 Japan Axial Spondyloarthritis Drugs Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Axial Spondyloarthritis Drugs Import and Export
• 5.7 Southeast Asia Axial Spondyloarthritis Drugs Market Analysis
  • 5.7.1 Southeast Asia Axial Spondyloarthritis Drugs Production
  • 5.7.2 Southeast Asia Axial Spondyloarthritis Drugs Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Axial Spondyloarthritis Drugs Import and Export
• 5.8 India Axial Spondyloarthritis Drugs Market Analysis
  • 5.8.1 India Axial Spondyloarthritis Drugs Production
  • 5.8.2 India Axial Spondyloarthritis Drugs Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Axial Spondyloarthritis Drugs Import and Export

6 Axial Spondyloarthritis Drugs Segment Market Analysis (by Type)

• 6.1 Global Axial Spondyloarthritis Drugs Production by Type
• 6.2 Global Axial Spondyloarthritis Drugs Revenue by Type
• 6.3 Axial Spondyloarthritis Drugs Price by Type

7 Axial Spondyloarthritis Drugs Segment Market Analysis (by Application)

• 7.1 Global Axial Spondyloarthritis Drugs Consumption by Application
• 7.2 Global Axial Spondyloarthritis Drugs Consumption Market Share by Application (2014-2019)

8 Axial Spondyloarthritis Drugs Major Manufacturers Analysis

• 8.1 AstraZeneca Plc
  • 8.1.1 AstraZeneca Plc Axial Spondyloarthritis Drugs Production Sites and Area Served
  • 8.1.2 AstraZeneca Plc Product Introduction, Application and Specification
  • 8.1.3 AstraZeneca Plc Axial Spondyloarthritis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Eli Lilly and Company
  • 8.2.1 Eli Lilly and Company Axial Spondyloarthritis Drugs Production Sites and Area Served
  • 8.2.2 Eli Lilly and Company Product Introduction, Application and Specification
  • 8.2.3 Eli Lilly and Company Axial Spondyloarthritis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Johnson & Johnson
  • 8.3.1 Johnson & Johnson Axial Spondyloarthritis Drugs Production Sites and Area Served
  • 8.3.2 Johnson & Johnson Product Introduction, Application and Specification
  • 8.3.3 Johnson & Johnson Axial Spondyloarthritis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Novartis AG
  • 8.4.1 Novartis AG Axial Spondyloarthritis Drugs Production Sites and Area Served
  • 8.4.2 Novartis AG Product Introduction, Application and Specification
  • 8.4.3 Novartis AG Axial Spondyloarthritis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Panacea Biotec Ltd
  • 8.5.1 Panacea Biotec Ltd Axial Spondyloarthritis Drugs Production Sites and Area Served
  • 8.5.2 Panacea Biotec Ltd Product Introduction, Application and Specification
  • 8.5.3 Panacea Biotec Ltd Axial Spondyloarthritis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Sandoz International GmbH
  • 8.6.1 Sandoz International GmbH Axial Spondyloarthritis Drugs Production Sites and Area Served
  • 8.6.2 Sandoz International GmbH Product Introduction, Application and Specification
  • 8.6.3 Sandoz International GmbH Axial Spondyloarthritis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Sun Pharma Advanced Research Company Ltd
  • 8.7.1 Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Production Sites and Area Served
  • 8.7.2 Sun Pharma Advanced Research Company Ltd Product Introduction, Application and Specification
  • 8.7.3 Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 UCB SA
  • 8.8.1 UCB SA Axial Spondyloarthritis Drugs Production Sites and Area Served
  • 8.8.2 UCB SA Product Introduction, Application and Specification
  • 8.8.3 UCB SA Axial Spondyloarthritis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Axial Spondyloarthritis Drugs Market

• 9.1 Global Axial Spondyloarthritis Drugs Market Trend Analysis
  • 9.1.1 Global Axial Spondyloarthritis Drugs Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Axial Spondyloarthritis Drugs Regional Market Trend
  • 9.2.1 North America Axial Spondyloarthritis Drugs Forecast 2019-2025
  • 9.2.2 Europe Axial Spondyloarthritis Drugs Forecast 2019-2025
  • 9.2.3 China Axial Spondyloarthritis Drugs Forecast 2019-2025
  • 9.2.4 Japan Axial Spondyloarthritis Drugs Forecast 2019-2025
  • 9.2.5 Southeast Asia Axial Spondyloarthritis Drugs Forecast 2019-2025
  • 9.2.6 India Axial Spondyloarthritis Drugs Forecast 2019-2025
• 9.3 Axial Spondyloarthritis Drugs Market Trend (Product Type)
• 9.4 Axial Spondyloarthritis Drugs Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Axial Spondyloarthritis Drugs Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List